Alnylam's Yvonne Greenstreet, at #STATSummit, predicts vutrisiran will become multibillion-dollar product for ...

Micky Tripathi, a top HHS official, said the election won’t impact AI regulations, despite fears that a Trump administration ...

The doctors said they lost control over their schedules, were told to prioritize coding patients’ illnesses, and felt like ...

Because of race-based estimates, thousands of Black patients were placed further down kidney transplant waitlists.

Today's health news includes highlights from the STAT Summit, a new option for people with HIV who need kidneys, and GLP-1s ...

STAT’s Matthew Herper picked Bristol Myers Squibb CEO Chris Boerner’s brain at the STAT Summit on all things related to the ...

The Senate report extensively cites STAT’s investigation of the use of algorithms and artificial intelligence within Medicare ...

Unfortunately, many of our elected leaders today undervalue the role of patents to progress the science of drug discovery and ...

Telehealth sites prescribing GLP-1s online can get off the ground in a matter of days by “renting” the services of these ...

Blue Note’s failure to clear the FDA hurdle offers a rare window into the regulatory challenges faced by digital therapeutics ...

Pitts, a former FDA associate commissioner, is president of the Center for Medicine in the Public Interest and a visiting ...

Republicans will need to rework Biden’s drug pricing law and let the expanded ACA subsidies end, should Trump take office.